New Zealand markets open in 9 hours 40 minutes

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9200+0.0100 (+0.52%)
At close: 04:00PM EST
1.9200 0.00 (0.00%)
Pre-market: 05:24AM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
17,667
18,256
258
4,742
0
Operating expenses
Research development
49,729
64,526
67,003
65,775
33,885
Selling general and administrative
43,009
41,701
21,440
15,588
12,887
Total operating expenses
101,593
106,227
79,371
67,958
42,806
Operating income or loss
-83,926
-87,971
-79,113
-63,216
-42,806
Interest expense
4,545
1,940
-
-
-
Total other income/expenses net
-14,422
-191
432
963
1,144
Income before tax
-102,426
-89,756
-78,280
-60,925
-41,662
Income from continuing operations
-102,426
-89,756
-78,280
-60,925
-41,662
Net income
-102,426
-89,756
-78,280
-60,925
-41,662
Net income available to common shareholders
-102,426
-89,756
-78,829
-60,925
-41,662
Basic EPS
-
-2.91
-3.52
-3.35
-2.60
Diluted EPS
-
-2.91
-3.52
-3.35
-2.60
Basic average shares
-
30,896
22,386
18,161
16,002
Diluted average shares
-
30,896
22,386
18,161
16,002
EBITDA
-
-87,170
-78,352
-62,466
-42,397